0,928  0,004  Antineoplastic (non-small cell lung cancer)
0,924  0,004  Antineoplastic (breast cancer)
0,922  0,004  Antineoplastic (colorectal cancer)
0,919  0,004  Antineoplastic (colon cancer)
0,917  0,005  Transcription factor NF kappa B inhibitor
0,905  0,004  Antineoplastic (melanoma)
0,894  0,003  Cytostatic
0,890  0,003  Antineoplastic (carcinoma)
0,882  0,003  Sensitization
0,880  0,008  Apoptosis agonist
0,867  0,005  Antileukemic
0,850  0,005  Antineoplastic (lung cancer)
0,845  0,003  Antineoplastic (squamous cell carcinoma)
0,794  0,005  Antineoplastic (ovarian cancer)
0,781  0,004  Nitric oxide antagonist
0,761  0,021  Antiinflammatory
0,739  0,007  Prostate cancer treatment
0,728  0,005  Antineoplastic (cervical cancer)
0,693  0,016  Teratogen
0,678  0,013  Carcinogenic
0,660  0,018  Embryotoxic
0,640  0,006  Antineoplastic (glioma)
0,633  0,010  Proliferative diseases treatment
0,630  0,012  Chemopreventive
0,617  0,012  Analeptic
0,613  0,008  Apoptosis antagonist
0,609  0,011  Cytotoxic
0,605  0,008  Antineoplastic (multiple myeloma)
0,602  0,017  Respiratory analeptic
0,590  0,005  Antineoplastic (liver cancer)
0,604  0,020  Antineoplastic (solid tumors)
0,591  0,012  Antineoplastic (pancreatic cancer)
0,585  0,015  Immunosuppressant
0,562  0,005  ICAM1 expression inhibitor
0,548  0,009  Antineoplastic (glioblastoma multiforme)
0,544  0,015  AR expression inhibitor
0,533  0,007  Carcinogenic, group 3
0,530  0,004  Protein kinase stimulant
0,556  0,033  TNF expression inhibitor
0,533  0,032  Antibacterial
0,519  0,019  Hepatic disorders treatment
0,528  0,036  CYP3A4 substrate
0,503  0,011  Antineoplastic (endocrine cancer)
0,498  0,009  Antineoplastic (sarcoma)
0,508  0,019  Cardiovascular analeptic
0,498  0,010  Antineoplastic (renal cancer)
0,492  0,013  Antineoplastic (lymphoma)
0,484  0,008  Hepatoprotectant
0,482  0,014  Antimitotic
0,453  0,027  Antineoplastic (brain cancer)
0,434  0,018  DNA synthesis inhibitor
0,423  0,012  Contraceptive
0,425  0,028  NOS2 expression inhibitor
0,397  0,010  VCAM1 expression inhibitor
0,419  0,032  Antioxidant
0,388  0,005  Antifungal enhancer
0,421  0,040  Antihypercholesterolemic
0,386  0,008  Antiviral (Influenza A)
0,418  0,040  Antifungal
0,419  0,044  Bone diseases treatment
0,377  0,014  Platelet adhesion inhibitor
0,372  0,014  UGT2B7 substrate
0,367  0,015  Antiviral (Influenza)
0,411  0,062  Antipruritic, allergic
0,367  0,022  Abortion inducer
0,352  0,014  Interferon gamma antagonist
0,369  0,033  Antihypoxic
0,360  0,027  Antineoplastic (lymphocytic leukemia)
0,366  0,034  Mutagenic
0,343  0,015  Hair growth stimulant
0,361  0,033  Antineoplastic (osteosarcoma)
0,333  0,008  Antineoplastic antibiotic
0,358  0,036  Hypoglycemic
0,360  0,039  Antiprotozoal (Leishmania)
0,347  0,029  Antihypertriglyceridemic
0,348  0,033  Antiparasitic
0,347  0,036  Antineoplastic (small cell lung cancer)
0,341  0,031  Antiulcerative
0,325  0,017  Lipocortins synthesis antagonist
0,321  0,017  Tubulin antagonist
0,345  0,045  UGT2B4 substrate
0,351  0,053  NOS3 expression inhibitor
0,342  0,045  Sodium/bile acid cotransporter inhibitor
0,330  0,043  Tumour necrosis factor alpha release inhibitor
0,311  0,029  UGT1A1 substrate
0,279  0,003  Microtubule formation inhibitor
0,391  0,116  Caspase 9 stimulant
0,328  0,057  Antiosteoporotic
0,304  0,034  UDP-glucuronosyltransferase substrate
0,348  0,082  CYP2C9 substrate
0,277  0,011  Carcinogenic, group 2B
0,288  0,023  Melanin inhibitor
0,266  0,004  Antineoplastic alkaloid
0,271  0,014  Topoisomerase I inhibitor
0,344  0,088  Antineoplastic (myeloid leukemia)
0,272  0,023  Antineoplastic (gastric cancer)
0,273  0,026  Antiacne
0,266  0,023  Prostate disorders treatment
0,247  0,014  ATPase inhibitor
0,271  0,038  Antihelmintic
0,256  0,026  UGT2B15 substrate
0,293  0,063  UGT1A9 substrate
0,232  0,002  Ca2+-transporting ATPase inhibitor
0,231  0,006  Actinic keratosis treatment
0,244  0,022  UGT2B9 substrate
0,282  0,062  Transcription factor STAT3 inhibitor
0,276  0,058  Free radical scavenger
0,255  0,038  Pneumotoxic
0,236  0,025  Genotoxic
0,292  0,083  Caspase 3 stimulant
0,233  0,027  Interleukin 6 antagonist
0,243  0,038  Antipruritic, non-allergic
0,254  0,060  UGT1A6 substrate
0,234  0,047  P-glycoprotein inhibitor
0,202  0,016  Growth stimulant
0,210  0,024  Arachidonic acid antagonist
0,188  0,006  Anabolic
0,222  0,040  UGT1A3 substrate
0,210  0,032  Antineoplastic (bone cancer)
0,238  0,060  Peptidyltransferase inhibitor
0,198  0,041  Antirickettsial
0,244  0,091  Transcription factor STAT inhibitor
0,240  0,092  Chemoprotective
0,158  0,014  CC chemokine 6 receptor antagonist
0,173  0,035  Cholesterol synthesis inhibitor
0,152  0,019  Antibiotic
0,202  0,071  Sedative
0,157  0,028  Contraceptive female
0,232  0,104  Immunostimulant
0,184  0,061  Liver fibrosis treatment
0,185  0,065  UGT1A4 substrate
0,131  0,019  Contraceptive male
0,241  0,129  Interleukin 2 agonist
0,125  0,014  Na+ K+ transporting ATPase inhibitor
0,174  0,069  Toxic, respiratory center
0,121  0,019  ATPase (Vacuolar H+) inhibitor
0,141  0,039  Expectorant
0,117  0,015  T cell inhibitor
0,186  0,091  Neurotrophic factor enhancer
0,213  0,119  CYP2C19 substrate
0,205  0,111  DNA damaging
0,166  0,074  UGT2B10 substrate
0,161  0,070  Antiviral (Herpes)
0,096  0,006  RNA-directed RNA polymerase stimulant
0,122  0,033  UGT2B11 substrate
0,174  0,089  Sepsis treatment
0,126  0,041  Sulfotransferase substrate
0,169  0,086  LDLR expression enhancer
0,091  0,010  Potassium channel Kv1.3 blocker
0,094  0,013  Hypercalcemia treatment
0,134  0,052  Interleukin 1b antagonist
0,222  0,142  CTGF expression inhibitor
0,125  0,046  Estrogen antagonist
0,101  0,022  HIV-1 integrase (Strand Transfer) inhibitor
0,205  0,127  Cardioprotectant
0,085  0,011  Postcoital contraceptive
0,092  0,018  Androgen agonist
0,126  0,056  Alcohol dehydrogenase substrate
0,106  0,038  Antispirochetal
0,194  0,127  5 Hydroxytryptamine release stimulant
0,101  0,034  Antiprotozoal activity enhancer
0,085  0,018  Protein 50S ribosomal subunit inhibitor
0,084  0,022  Estrogen agonist
0,067  0,008  Microtubule stabilization
0,084  0,026  Aromatase inhibitor
0,078  0,023  Postmenopausal disorders treatment
0,211  0,155  Cholesterol antagonist
0,073  0,019  Lipocortins synthesis agonist
0,086  0,032  Glycine receptor agonist
0,078  0,024  Antimycoplasmal
0,201  0,150  Hypoxia-inducible factor 1 alpha inhibitor
0,143  0,093  Prostatic (benign) hyperplasia treatment
0,131  0,083  Lipid peroxidase inhibitor
0,211  0,164  Antithrombotic
0,109  0,063  Electron transport complex I inhibitor
0,128  0,086  Farnesoid X receptor antagonist
0,053  0,014  Hypogonadism treatment
0,178  0,139  Spasmolytic
0,139  0,100  Muscle relaxant
0,131  0,096  NOS3 expression enhancer
0,052  0,018  Parathyroid hormone antagonist
0,099  0,066  Estrogen receptor beta antagonist
0,091  0,060  Thioredoxin inhibitor
0,082  0,054  Glycine receptor antagonist
0,100  0,072  UGT2B1 substrate
0,046  0,018  Estrogen receptor alpha agonist
0,032  0,006  Vitamin D receptor antagonist
0,104  0,084  Alkylator
0,068  0,048  SULT2A1 substrate
0,101  0,085  Topoisomerase II inhibitor
0,082  0,066  Transcription factor NF kappa B stimulant
0,151  0,135  Hypolipemic
0,080  0,064  Antiviral (Trachoma)
0,126  0,111  Adenylate cyclase stimulant
0,035  0,021  Tubulin agonist
0,060  0,047  HIV-1 integrase (3'-Processing) inhibitor
0,085  0,072  SULT1E1 substrate
0,073  0,063  Antitreponemal
0,020  0,012  Progesterone receptor B antagonist
0,052  0,045  Beta tubulin antagonist
0,120  0,113  Eye irritation, high
0,035  0,029  5-Alpha-reductase inhibitor
0,026  0,022  Retinoid X gamma receptor antagonist
0,020  0,017  Corticosteroid-like
0,031  0,030  HMG CoA reductase inhibitor
0,074  0,073  Androgen antagonist

